U.S. Geriatric Rehabilitation Devices Market

Market Outlook

By 2032, the U.S. Geriatric Rehabilitation Devices Market is projected to reach approximately USD 9.48 billion, expanding at a CAGR of 10.32% during the forecast period 2027–2032. The market stands at USD 5.26 billion in 2026, following historical expansion from USD 3.97 billion in 2023 to USD 4.34 billion in 2024 and USD 4.77 billion in 2025. Values throughout this report are expressed in USD billions.

The market is moving into a structurally stronger demand cycle as aging, multimorbidity, post-surgical recovery, fall prevention, neurological impairment, and age-related functional decline converge with a healthcare system increasingly focused on preserving independence. Americans aged 65 and older now represent close to one-fifth of the U.S. population. Recent U.S. population data show more than 61 million adults aged 65 and above, while newer population estimates place the national 65+ share near 19%. This population is not only becoming larger but is surviving longer with musculoskeletal, neurological, cardiopulmonary, balance, and mobility limitations that create recurring rehabilitation requirements.

Clinical burden strongly supports device utilization. More than 14 million U.S. adults aged 65 and older report a fall each year. Older-adult falls generate approximately 3 million emergency department visits, about 1 million hospitalizations, and nearly 319,000 hip-fracture hospitalizations annually. Diagnosed arthritis affects approximately 47.8% of noninstitutionalized Americans aged 65 and older, while stroke remains a major source of acquired disability, with more than 795,000 strokes occurring nationally each year. These conditions create demand for mobility aids, transfer systems, therapeutic exercise equipment, neuromuscular stimulation, balance systems, gait-training platforms, robotic rehabilitation equipment, positioning devices, and home-use rehabilitation technologies.

Market expansion is being accelerated by a fundamental change in care delivery. Geriatric rehabilitation is increasingly distributed across hospitals, inpatient rehabilitation facilities, skilled nursing facilities, outpatient clinics, assisted living communities, home health programs, and the patient’s own home. Medicare remains central to this ecosystem. Total Medicare enrollment has moved above 70 million beneficiaries, with more than 90% aged 65 or older. In fee-for-service Medicare alone, skilled nursing facilities treated approximately 1.1 million users in 2024, home health agencies served 2.6 million, and inpatient rehabilitation facilities treated approximately 377,000 patients. The scale of this post-acute infrastructure creates a durable installed base for rehabilitation-device procurement.

The market trajectory from USD 5.26 billion in 2026 to USD 9.48 billion in 2032 reflects more than demographic growth. Revenue expansion will increasingly come from premium product mix, sensor-assisted mobility, connected therapy, powered transfer equipment, home rehabilitation platforms, remote therapeutic monitoring, rehabilitation robotics, AI-supported movement assessment, and higher utilization among the oldest-old population. Device manufacturers that can demonstrate functional outcomes, caregiver-efficiency gains, safe discharge support, reduced fall risk, and lower total episode-of-care costs will be positioned to outperform conventional equipment suppliers.

Introduction

According to the U.S. Geriatric Rehabilitation Devices Market Report, geriatric rehabilitation represents a distinct medical-device opportunity because elderly patients typically require longer recovery pathways, greater assistance with mobility, more multidisciplinary care, and higher levels of functional support than younger rehabilitation populations. The commercial opportunity therefore extends beyond physical therapy equipment into mobility restoration, transfer safety, strengthening, balance training, neuromuscular re-education, ADL support, neurological recovery, and home-based rehabilitation.

For market purposes, geriatric rehabilitation devices include equipment primarily used to restore, maintain, measure, or support functional mobility and physical independence in adults aged 65 and older. The scope includes manual and powered mobility equipment, patient transfer products used within rehabilitation pathways, therapy tables and exercise systems, electrotherapy equipment, balance and gait-training systems, rehabilitation robotics, sensor-enabled therapy products, and clinically oriented assistive devices. Purely recreational fitness equipment and products without a meaningful rehabilitation function are excluded.

The addressable population continues to broaden. The U.S. population aged 65 and older increased to approximately 61.2 million in 2024, rising more than 3% in a single year. Older Americans are also living nearly two decades beyond age 65 on average. This longevity creates a widening interval during which patients may require rehabilitation following joint replacement, fracture, stroke, hospitalization, prolonged deconditioning, arthritis progression, Parkinsonian impairment, cardiopulmonary disease, or repeated falls.

The market is especially sensitive to functional status rather than diagnosis alone. An elderly patient may simultaneously have osteoarthritis, balance impairment, hypertension, weakness after hospitalization, and fear of falling. As a result, the same patient can generate demand across several device categories over time: a walker during initial recovery, strength and balance equipment during supervised rehabilitation, an electrotherapy device for pain management, transfer aids for home use, and connected monitoring tools for continued therapy adherence.

This creates attractive recurring economics for manufacturers with broad rehabilitation platforms. Procurement is increasingly shifting from isolated equipment purchases toward integrated pathways that support evaluation, therapy, discharge, home recovery, and long-term mobility. Hospitals and post-acute providers are asking whether devices reduce therapist burden, improve patient throughput, shorten recovery time, support safe transfers, enable earlier discharge, and document measurable functional progress.

Key Market Drivers: What’s Fueling the U.S. Geriatric Rehabilitation Devices Market Boom?

The most important structural driver is the rapid expansion of the older U.S. population. People aged 65 and older represented approximately 18% of the U.S. population in 2024 and are approaching 19% under newer population estimates. Unlike population growth in younger cohorts, aging has an amplified effect on rehabilitation demand because utilization rises substantially with age. The 75–84 and 85+ cohorts have disproportionately higher exposure to falls, frailty, joint degeneration, stroke, hospitalization, mobility limitations, and caregiver dependence.

Falls represent one of the strongest direct demand generators. More than one in four older adults reports falling in a typical year, translating to more than 14 million people. Roughly 37% of older adults who fall report an injury requiring treatment or restricting activity, creating millions of episodes in which mobility retraining, strengthening, balance therapy, assistive devices, transfer equipment, and home-safety rehabilitation become clinically relevant. Nearly 319,000 older Americans are hospitalized for hip fractures annually, creating a particularly device-intensive pathway spanning acute hospitalization, post-acute rehabilitation, and home recovery.

Musculoskeletal disease is another major driver. Approximately 47.8% of noninstitutionalized adults aged 65 and older report diagnosed arthritis. Degenerative joint disease directly affects walking tolerance, stair negotiation, transfers, strength, and activities of daily living. The result is sustained demand for therapeutic exercise platforms, resistance systems, mobility aids, electrotherapy, heat and cold therapy, gait-training devices, and post-operative rehabilitation equipment.

Neurological rehabilitation contributes a higher-value technology opportunity. The United States records more than 795,000 strokes per year, while stroke prevalence among adults aged 65 and older is materially higher than among younger populations. Stroke survivors may require gait training, upper- and lower-extremity therapy, neuromuscular electrical stimulation, balance intervention, robotic rehabilitation, functional electrical stimulation, and long-duration outpatient or home programs. Parkinson’s disease, peripheral neuropathy, traumatic brain injury, and other age-associated neurological conditions further increase demand.

The economics of post-acute Medicare care reinforce equipment utilization. In 2024, fee-for-service Medicare spending reached approximately USD 31 billion across skilled nursing facilities, USD 15.7 billion across home health agencies, and USD 11 billion across inpatient rehabilitation facilities. Skilled nursing facilities treated about 1.1 million FFS Medicare users, home health agencies 2.6 million, and inpatient rehabilitation facilities approximately 377,000. These facilities are major procurement environments for mobility, transfer, therapeutic exercise, positioning, fall-prevention, and neurological rehabilitation technologies.

Home-based rehabilitation is becoming equally important. Health systems are under financial pressure to reduce avoidable inpatient days and transition clinically appropriate patients to lower-cost settings. At the same time, many older adults strongly prefer aging in place. Portable stimulation devices, compact exercise systems, home-use mobility products, connected therapy devices, wearable sensors, and remote therapeutic monitoring platforms allow rehabilitation to continue after discharge without requiring repeated high-cost facility utilization.

Medicare payment policy also influences product adoption. Medicare Part B covers qualifying durable medical equipment including wheelchairs and power mobility equipment when medical-necessity requirements are met. In 2026, CMS applied a 2% update factor to certain DMEPOS fee-schedule amounts not adjusted using competitive-bidding information. For therapy services, the 2026 KX modifier threshold is USD 2,480 for physical therapy and speech-language pathology combined and USD 2,480 for occupational therapy. These policies influence referral patterns, documentation requirements, supplier economics, and the commercial viability of rehabilitation technologies.

Hospital and health-system procurement behavior is becoming more disciplined. Equipment is increasingly assessed on therapist productivity, treatment capacity, patient handling safety, documentation integration, maintenance burden, space requirements, utilization rates, and outcomes rather than acquisition price alone. A premium gait system that supports more patients per day or a powered transfer solution that reduces staff injury exposure can create a stronger business case than lower-cost conventional equipment.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in geriatric rehabilitation is shifting from passive equipment toward systems that measure, guide, adapt, and document therapy. Traditional rehabilitation products will remain essential, but the fastest value creation is occurring where hardware is combined with sensing, software, powered assistance, robotics, and connectivity.

Robotic rehabilitation is one of the most visible innovation areas. Robotic gait trainers, powered exoskeletons, upper-extremity systems, and electromechanical therapy platforms can deliver highly repetitive movement training while collecting objective performance information. For elderly neurological patients, particularly following stroke, these systems can increase therapy intensity without requiring a proportional increase in therapist physical effort. Their commercial limitation remains high capital cost, but declining component costs and improving reimbursement pathways are gradually increasing addressability.

Sensor-assisted rehabilitation is expanding more broadly. Force measurement, motion tracking, inertial sensors, pressure mapping, gait analysis, digital balance assessment, and connected resistance systems can provide objective evidence of progress. This is important in geriatric care because functional improvements may be gradual and difficult to quantify through subjective observation alone. Systems that demonstrate changes in gait symmetry, range of motion, sit-to-stand performance, balance, walking endurance, or exercise adherence can strengthen clinical documentation and value-based care arguments.

Remote therapeutic monitoring is creating another strategic layer. CMS has continued to incorporate remote therapeutic monitoring into therapy-related coding and added additional RTM codes for 2026. This strengthens the case for rehabilitation products that can transmit adherence, musculoskeletal, functional, or activity information between the patient’s home and clinical teams. The strongest devices will not attempt to replace therapists; they will extend therapist visibility between in-person sessions.

Patient-handling innovation is also relevant to geriatric rehabilitation. Powered sit-to-stand systems, ceiling lifts, transfer aids, advanced wheelchairs, pressure-management seating, and adjustable therapy surfaces can reduce physical strain on caregivers while supporting safer mobilization. This matters commercially because labor scarcity and musculoskeletal injury among healthcare workers increase the economic value of equipment that allows one caregiver to perform tasks that previously required two.

Electrotherapy is becoming more portable and personalized. Modern TENS, NMES, functional electrical stimulation, ultrasound, and combination therapy systems increasingly offer programmable protocols, portable designs, and patient-specific settings. For older adults recovering from surgery, living with chronic musculoskeletal pain, or rebuilding muscle after hospitalization, portable electrotherapeutic devices can bridge supervised and home rehabilitation.

The next innovation cycle will therefore be defined less by standalone machinery and more by measurable rehabilitation ecosystems. Manufacturers that connect assessment, intervention, mobility, progress tracking, and home adherence will have greater strategic relevance to U.S. providers than suppliers competing only on individual hardware specifications.

Segmentation Insights

The U.S. Geriatric Rehabilitation Devices Market is segmented on the basis of product category, application, end user, technology type, age group, and region.

By Product Category

Mobility and transfer devices represent the largest product category, accounting for approximately USD 1.58 billion in 2026, or 30.0% of the market. This segment includes walkers, rollators, wheelchairs, mobility-support systems, transfer aids, patient lifts, sit-to-stand equipment, and related positioning products. Demand is structurally linked to increasing age and functional dependency. National evidence has consistently shown that mobility-device utilization rises sharply among adults in their eighties and nineties, making this category one of the clearest beneficiaries of population aging.
Therapeutic exercise and strengthening equipment represents approximately USD 1.05 billion, or 20.0% of 2026 revenue. Products include resistance systems, cycle ergometers, parallel bars, therapy stairs, pulley systems, recumbent equipment, range-of-motion devices, and lower- or upper-extremity strengthening systems. The category benefits from the high prevalence of arthritis, post-operative weakness, sarcopenia, and hospital-associated deconditioning among elderly patients. Demand is increasingly shifting toward low-impact systems that allow controlled loading and measurable progression.
Electrotherapy and pain-management devices account for approximately USD 0.79 billion, representing 15.0% of the market. TENS, NMES, functional electrical stimulation, therapeutic ultrasound, combination electrotherapy systems, heat therapy, and related modalities remain widely used across musculoskeletal and neurological rehabilitation. The segment benefits from the fact that nearly half of older noninstitutionalized Americans have diagnosed arthritis, while chronic pain frequently coexists with reduced physical activity and functional decline.
Balance and fall-prevention systems generate approximately USD 0.66 billion, or 12.5% of 2026 revenue. The addressable clinical need is unusually large: more than 14 million older Americans report falling annually, with millions sustaining injuries. Balance platforms, gait-assessment equipment, perturbation systems, stability trainers, parallel bars, and fall-risk measurement technologies are increasingly incorporated into geriatric therapy because fall prevention can protect both patient independence and payer economics.
Rehabilitation robotics and sensor-assisted gait systems account for approximately USD 0.53 billion, or 10.1% of the market, but represent the fastest-growing product category. Robotic gait systems, powered exoskeletons, body-weight-support systems, computerized gait trainers, sensor-based neurological systems, and AI-assisted rehabilitation equipment are gaining acceptance in advanced rehabilitation centers. This segment is projected to grow well above the overall market rate as health systems seek higher therapy intensity, objective outcome measurement, and differentiated neurological programs.
Activities-of-daily-living, positioning, and assistive rehabilitation devices contribute approximately USD 0.65 billion, or 12.4% of 2026 revenue. Products include adaptive seating, positioning systems, bathroom rehabilitation aids, reach and grip devices, transfer-support products, and other equipment intended to restore functional independence. Demand is particularly strong among older adults with multi-morbidity, severe arthritis, neurological impairment, or post-hospitalization weakness.

By Application

Orthopedic and post-surgical rehabilitation is the largest application segment at approximately USD 1.47 billion in 2026, representing 28.0% of the market. Hip fracture, joint degeneration, joint replacement, spinal disorders, fractures, and other orthopedic interventions create a broad need for walking aids, therapeutic exercise, range-of-motion equipment, electrotherapy, balance training, and home rehabilitation. Nearly 319,000 older Americans are hospitalized for hip fractures each year, illustrating the scale of a single geriatric orthopedic pathway.
Neurological rehabilitation contributes approximately USD 1.10 billion, or 20.9% of market value. Stroke, Parkinsonian conditions, neuropathy, acquired brain injury, and other neurological disorders create demand for gait training, FES, neuromuscular stimulation, balance rehabilitation, robotic systems, and repetitive task training. With more than 795,000 strokes occurring in the United States annually and stroke prevalence rising materially with age, elderly neurological rehabilitation remains one of the strongest opportunities for premium technology.
Frailty, weakness, and deconditioning rehabilitation accounts for approximately USD 0.95 billion, representing 18.1% of 2026 demand. This application is expanding as elderly patients survive increasingly complex acute-care episodes but leave hospitals with reduced walking endurance, muscle strength, and independence. Strengthening systems, cycle ergometers, standing aids, transfer equipment, and progressive mobility devices are commonly used to prevent further decline and support discharge.
Fall prevention and balance rehabilitation generates approximately USD 0.79 billion, or 15.0% of the market. Falls are the leading cause of injury among U.S. adults aged 65 and older, creating strong clinical and economic incentives for balance screening, gait training, lower-extremity strengthening, assistive-device prescription, and home transition planning. This application is expected to expand as health plans and senior-care systems increasingly treat fall prevention as a measurable quality and cost-management objective.
Cardiopulmonary and endurance rehabilitation contributes approximately USD 0.53 billion, or 10.1% of 2026 value. Older adults recovering from cardiac events, pulmonary disease, prolonged hospitalization, or major surgery frequently require graded exercise and monitored reconditioning. Low-impact cycles, supported treadmills, resistance equipment, mobility systems, and connected exercise technologies are important in restoring endurance while minimizing fall and overexertion risk.
Chronic pain and arthritis rehabilitation accounts for approximately USD 0.42 billion, or 8.0% of market revenue. Diagnosed arthritis affects around 47.8% of adults aged 65 and older living outside institutions. Therapeutic heat, electrical stimulation, ultrasound, strengthening, mobility products, and joint-protection equipment allow providers to address pain while maintaining function. This segment is relatively mature but retains significant recurring demand because arthritis is chronic rather than episodic.

By End User

Home healthcare and home-based rehabilitation is the largest end-user category, representing approximately USD 1.63 billion, or 31.0% of the market in 2026. Home rehabilitation is gaining importance as hospitals discharge elderly patients earlier, Medicare Advantage organizations intensify utilization management, and older adults favor aging in place. Home health agencies served approximately 2.6 million fee-for-service Medicare users in 2024 alone, demonstrating the scale of the care channel. Portable mobility aids, compact therapeutic exercise equipment, stimulation devices, connected rehabilitation tools, and home transfer products are the strongest demand areas.
Skilled nursing facilities and long-term care facilities account for approximately USD 1.16 billion, or 22.1% of 2026 revenue. There were approximately 14,500 skilled nursing facilities participating in FFS Medicare activity in 2024, serving around 1.1 million beneficiaries and generating approximately USD 31 billion in Medicare spending. Rehabilitation devices in this setting must support high utilization, durability, infection-control requirements, therapist efficiency, and a wide range of functional impairment.
Hospitals and inpatient rehabilitation facilities represent approximately USD 1.05 billion, or 20.0% of market value. Inpatient rehabilitation facilities treated approximately 377,000 FFS Medicare patients in 2024, with Medicare spending around USD 11 billion. These environments represent the highest-value procurement channel for advanced gait systems, robotics, neurological rehabilitation, patient transfer systems, computerized balance platforms, and multidisciplinary rehabilitation infrastructure.
Outpatient physical and occupational therapy centers generate approximately USD 0.95 billion, or 18.1% of 2026 demand. Outpatient providers serve patients who no longer need institutional care but continue to require supervised recovery. Procurement favors versatile equipment that can support high patient turnover across arthritis, post-joint-replacement, neurological, balance, and chronic pain cases. Medicare’s 2026 therapy policy, including the USD 2,480 KX threshold for PT/SLP and a separate USD 2,480 threshold for OT, remains relevant to utilization and documentation behavior.
Assisted living communities, senior-care programs, and community rehabilitation settings contribute approximately USD 0.47 billion, or 8.9% of market value. These settings increasingly use mobility, strengthening, balance, transfer, and wellness-to-rehabilitation equipment to preserve resident independence and delay higher-acuity care. Their commercial importance is likely to rise because functional decline often begins before an older adult requires skilled nursing care.

By Technology Type

Mechanical and conventional rehabilitation technologies remain the largest category at approximately USD 1.84 billion, or 35.0% of the 2026 market. Manual walkers, therapy tables, parallel bars, resistance devices, conventional wheelchairs, transfer products, and non-powered exercise equipment remain essential because they are cost-effective, familiar to clinicians, relatively easy to maintain, and applicable across nearly every rehabilitation setting.
Powered and electromechanical systems account for approximately USD 1.16 billion, or 22.1% of revenue. Powered mobility devices, motorized therapeutic equipment, electromechanical gait trainers, powered transfer systems, adjustable rehabilitation surfaces, and advanced exercise equipment are gaining share as providers seek greater patient independence and reduced caregiver burden.
Electrotherapeutic technologies contribute approximately USD 0.79 billion, or 15.0% of market value. This segment includes TENS, NMES, FES, therapeutic ultrasound, combination therapy, and other energy-based modalities. Portable devices are increasing the addressable opportunity by allowing therapy to move beyond the clinic into home-based recovery.
Connected and sensor-enabled rehabilitation systems represent approximately USD 0.68 billion, or 12.9% of 2026 revenue. Motion sensors, gait-analysis tools, force platforms, digital balance assessment, connected exercise systems, and app-linked devices provide objective functional information. These technologies are gaining strategic value because they improve documentation and allow clinicians to quantify progress rather than relying exclusively on subjective observation.
Robotic and AI-supported rehabilitation technologies account for approximately USD 0.47 billion, or 8.9% of the market, with an above-market growth trajectory through 2032. Robotic gait systems, exoskeletons, intelligent resistance systems, adaptive therapy devices, and AI-assisted movement analysis are concentrated in advanced rehabilitation centers today but are expected to expand as clinical evidence, usability, and reimbursement improve.
Wearable and remote therapeutic monitoring technologies generate approximately USD 0.32 billion, or 6.1% of market value. This is the smallest technology category but one of the most strategically important. Wearable motion tracking, connected therapeutic devices, home exercise monitoring, and RTM-compatible rehabilitation technologies support longitudinal care and may help providers preserve visibility into patient progress after discharge.

By Age Group

Adults aged 65–74 account for approximately USD 1.63 billion, or 31.0% of 2026 revenue. This cohort is the largest by population but has lower device intensity per person than older groups. Demand is weighted toward post-surgical orthopedic rehabilitation, arthritis management, strengthening, active recovery, and outpatient or home-based technologies.
Adults aged 75–84 represent the largest value cohort at approximately USD 2.00 billion, or 38.0% of the market. This group combines substantial population scale with sharply higher rates of mobility limitation, joint degeneration, fall exposure, cardiovascular disease, neurological impairment, and hospitalization. It is particularly important for walkers, transfer devices, gait rehabilitation, balance equipment, therapeutic exercise systems, and home recovery products.
Adults aged 85 and older account for approximately USD 1.63 billion, or 31.0% of market value despite representing a much smaller share of the U.S. population. Device intensity is highest in this group because mobility assistance, transfer support, fall prevention, positioning, and caregiver-dependent rehabilitation become more common with advancing age. National research has shown extremely steep increases in mobility-device use in the oldest age groups, making the 85+ population disproportionately important to market economics.

Regional Insights: Where the Market is Growing Fastest

The U.S. Geriatric Rehabilitation Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance is shaped by the absolute number of older residents, the percentage of the population aged 65 and above, Medicare enrollment, post-acute facility density, migration patterns, orthopedic and neurological procedure volumes, hospital investment, rural access, and the penetration of home-based care.

South

The South is the largest regional market, representing approximately USD 1.89 billion in 2026, or 35.9% of national demand. The region is projected to approach USD 3.42 billion by 2032, representing growth of approximately 10.4% annually. Its leadership reflects the combination of large population centers, strong retiree migration, high chronic-disease burden, large Medicare populations, extensive post-acute infrastructure, and continuing hospital expansion.

Florida is the most geriatric-intensive large state in the region. Its population exceeded 23 million in 2025, and approximately 22.8% of residents are aged 65 or older. That demographic profile supports exceptionally strong demand for mobility products, fall-prevention equipment, orthopedic rehabilitation, neurological recovery, home-use therapy systems, and assisted-living rehabilitation infrastructure. South Florida, Tampa Bay, Orlando, Jacksonville, and the Gulf Coast contain particularly large concentrations of elderly patients and senior-care facilities.

Texas operates differently. Approximately 15% of the state population is aged 65 and older, materially below Florida’s share, but Texas has more than 31 million residents. Its absolute elderly population therefore makes it one of the largest state-level rehabilitation markets in the country. Houston, Dallas-Fort Worth, San Antonio, and Austin support major hospital systems, orthopedic programs, neurological rehabilitation facilities, and post-acute networks. Rapid population growth gives Texas a stronger volume-growth profile than many older Northeastern states.

North Carolina, Georgia, Tennessee, and Virginia are increasingly important. These states combine older-adult population growth with expanding metropolitan healthcare infrastructure. North Carolina and Tennessee have strong rehabilitation and orthopedic networks, while Virginia benefits from high healthcare utilization in its major metropolitan corridors. Georgia is developing into a larger home-health and post-acute market as Atlanta and surrounding regions continue to expand.

West Virginia, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, and Oklahoma have smaller commercial markets but high functional-disease burden. Rurality, arthritis, stroke, cardiometabolic disease, and limited rehabilitation access create a strong need for scalable mobility and home-rehabilitation technologies. Manufacturers that require intensive on-site servicing may face distribution challenges in these states, while portable and remotely supported devices can have greater strategic relevance.

The South will retain national leadership through 2032 because it combines the largest addressable elderly population with continuing in-migration, relatively high fall and chronic-disease burden, and expanding home-health utilization.

West

The West accounts for approximately USD 1.21 billion, or 23.0% of 2026 market value, and is expected to be the fastest-growing region, reaching roughly USD 2.30 billion by 2032 at an annual growth rate above 11%.

California remains the largest individual state market in the West. Approximately 17.5% of California residents are aged 65 and older, and the state population remains near 39 million. California combines a large elderly patient pool with sophisticated academic medicine, rehabilitation hospitals, technology adoption, digital-health infrastructure, and high concentrations of neurological and orthopedic specialists. It is a priority market for robotic rehabilitation, sensor-based systems, connected therapy, and advanced mobility products.

Arizona has an especially attractive demographic structure. Approximately 20.6% of the state population is aged 65 and older, reflecting its longstanding role as a retirement destination. Phoenix, Scottsdale, Tucson, and surrounding retirement communities create dense demand for fall-prevention, mobility, orthopedic rehabilitation, cardiopulmonary reconditioning, and home-care technologies.

Oregon also has a comparatively aged population, with the 65+ share around one-fifth or higher under recent population datasets. Washington, Colorado, Nevada, and Utah generally have younger statewide profiles but strong population growth and sophisticated healthcare markets. Nevada and Arizona benefit directly from older-adult migration, while Washington and Colorado are strong markets for digital and connected rehabilitation technologies.

The West’s competitive advantage is its willingness to adopt technology. Rehabilitation robotics, remote therapeutic monitoring, wearable motion analysis, AI-supported gait assessment, and connected home-rehabilitation systems tend to gain commercial traction earlier in major Western health systems than in many cost-constrained rural markets.

Northeast

The Northeast represents approximately USD 1.11 billion, or 21.1% of the 2026 market, increasing toward approximately USD 1.90 billion by 2032. Its growth rate is below the West and South because total population expansion is slower, but it remains one of the highest-value markets per older resident due to advanced provider infrastructure and a highly aged demographic base.

Maine is particularly notable, with approximately 24.6% of residents aged 65 or older, one of the highest state shares in the United States. Pennsylvania also has a highly mature geriatric population, with approximately 21.4% of residents aged 65 and above. New York combines an elderly share around 19.3% with a population of roughly 20 million, making it one of the largest absolute demand centers.

Massachusetts, Connecticut, New Jersey, Rhode Island, Vermont, and New Hampshire support high-value rehabilitation purchasing despite smaller populations. Academic medical centers and major integrated systems in Boston, New York, Philadelphia, Pittsburgh, northern New Jersey, and Connecticut frequently serve as early evaluators of rehabilitation robotics, gait systems, neurological therapy platforms, and evidence-intensive technologies.

The Northeast is also attractive for post-acute rehabilitation because of high hospital density, substantial skilled nursing infrastructure, and significant Medicare utilization. Procurement tends to be rigorous. Manufacturers typically require strong clinical evidence, outcome data, cybersecurity readiness for connected devices, implementation support, and credible economic justification.

Midwest

The Midwest accounts for approximately USD 1.05 billion, or 20.0% of national market value in 2026, increasing toward USD 1.86 billion by 2032. The region combines an aging population, high arthritis and chronic-disease burden, mature hospital systems, large skilled nursing networks, and strong regional rehabilitation programs.

Ohio is a particularly important geriatric market, with approximately 20.2% of residents aged 65 or older. Michigan has a similarly mature population, with roughly 20.5% aged 65 and above. These states support significant demand for orthopedic rehabilitation, stroke recovery, mobility equipment, chronic pain treatment, and post-acute care.

Illinois remains the region’s largest metropolitan healthcare market, driven by Chicago and surrounding health systems. Minnesota is strategically important due to its medtech ecosystem and high-quality rehabilitation infrastructure. Wisconsin, Indiana, Missouri, Iowa, Kansas, and Nebraska provide stable demand, particularly for conventional mobility, therapeutic exercise, and post-acute equipment.

Rural portions of the Midwest create a different commercial problem. Older adults may live far from specialized outpatient rehabilitation. This increases the value of home-use equipment, durable mobility devices, connected rehabilitation, and regional referral models. The Midwest is therefore unlikely to be the fastest-growing region, but it should remain one of the most stable and defensible markets for manufacturers with strong distributor networks and service reliability.

Key Market Players

The U.S. competitive landscape is fragmented between diversified rehabilitation-device manufacturers, mobility specialists, patient-handling companies, electrotherapy suppliers, and emerging robotic-rehabilitation firms. Conventional product categories compete heavily on reliability, distribution, reimbursement familiarity, service support, and pricing. Advanced categories compete more on clinical evidence, software, connectivity, outcomes measurement, and workflow productivity.

The following are 15 highly relevant companies within the U.S. geriatric rehabilitation-device ecosystem:

Enovis Corporation – Chattanooga
Medline Industries
Drive DeVilbiss Healthcare
Sunrise Medical
Permobil
Pride Mobility Products
GF Health Products
Arjo
Dynatronics
Ekso Bionics
Lifeward
DIH Medical – Hocoma
BTL Industries
Mettler Electronics
Ottobock

Enovis has a particularly strong position in rehabilitation modalities through Chattanooga, covering electrotherapy, ultrasound, stimulation, shockwave, treatment surfaces, and related therapy equipment. Medline, Drive DeVilbiss, Sunrise Medical, Permobil, Pride Mobility, GF Health Products, and Arjo participate heavily in mobility, home care, patient handling, seating, transfer, and institutional equipment.

Dynatronics, BTL, and Mettler compete more directly in therapy modalities and physical rehabilitation equipment. Ekso Bionics, Lifeward, and DIH/Hocoma represent the technology-intensive end of the market through robotics, exoskeletons, gait training, and neurological rehabilitation. Ottobock brings advanced mobility and rehabilitation expertise across complex patient populations.

Competitive advantage will increasingly depend on access to U.S. health systems, Medicare-compatible documentation, distributor quality, therapy workflow integration, evidence generation, staff training, and post-sale service. Companies selling capital equipment must also demonstrate utilization economics because rehabilitation providers are unlikely to accept premium pricing for systems that cannot maintain sufficient patient throughput.

Recent Developments

The regulatory and reimbursement environment in 2026 is becoming increasingly important to geriatric rehabilitation-device strategy. CMS applied a 2% update factor to certain DMEPOS fee-schedule amounts for calendar year 2026, influencing reimbursement economics for qualifying durable equipment. Manufacturers and suppliers must continue to design commercial models around Medicare coding, medical-necessity documentation, supplier enrollment, and product-specific coverage requirements.

CMS also established 2026 KX modifier thresholds of USD 2,480 for physical therapy and speech-language pathology combined and USD 2,480 for occupational therapy. At the same time, CMS expanded the therapy framework around remote services and remote therapeutic monitoring. This strengthens the commercial rationale for rehabilitation technology capable of supporting measurable home exercise, musculoskeletal monitoring, functional adherence, and ongoing therapist oversight.

Prior authorization is becoming another important operational issue. CMS has announced an expansion of the Required Prior Authorization List for selected DMEPOS categories beginning in late 2026. Certain orthoses, pressure-reducing support surfaces, and a manual wheelchair base are among the affected categories. The change increases the importance of documentation quality, supplier workflow, and payer-navigation capabilities for companies operating in geriatric mobility and post-acute markets.

Advanced mobility reimbursement is also evolving. During 2025 and 2026, Lifeward reported progress obtaining Medicare Advantage authorization and payment for its personal robotic exoskeleton across major national plans. Exoskeletons remain a highly specialized segment rather than a mass geriatric device category, but broader payer acceptance is strategically important because it demonstrates that reimbursement can expand beyond conventional walkers, wheelchairs, and braces when clinical necessity and functional outcomes can be documented.

The competitive direction of the industry is also changing toward connected rehabilitation. Manufacturers are expanding sensor-enabled products, digital progress tracking, home-use therapy systems, robotic gait training, portable stimulation, and workflow software. Provider buying decisions are increasingly influenced by whether the device can generate usable rehabilitation data, integrate with care pathways, and continue to deliver value after the patient leaves the facility.

Conclusion

The U.S. Geriatric Rehabilitation Devices Market Size & Share is positioned for accelerated expansion from USD 5.26 billion in 2026 to approximately USD 9.48 billion by 2032, representing a 10.32% CAGR during the 2027–2032 forecast period. Historical market value increased from USD 3.97 billion in 2023 to USD 4.34 billion in 2024 and USD 4.77 billion in 2025, establishing a strong growth base before the current forecast cycle.

The central demand driver is not aging alone. The more important commercial factor is the growing number of older adults living longer with recoverable or manageable functional impairment. Falls affect more than 14 million older Americans annually, arthritis affects nearly half of adults aged 65 and above living outside institutions, and stroke continues to create hundreds of thousands of new rehabilitation episodes every year. These clinical pressures intersect with a Medicare program serving more than 70 million people and a post-acute system containing thousands of skilled nursing facilities, home health agencies, and inpatient rehabilitation facilities.

Mobility and transfer devices will remain the largest product category, while robotic, connected, and sensor-assisted technologies will generate the strongest premium growth. Orthopedic rehabilitation will maintain the largest application base, but neurological rehabilitation, fall prevention, and frailty management will increase in commercial importance. Home rehabilitation will become the dominant care-setting opportunity as health systems shorten institutional recovery and extend therapy into the patient’s residence.

Geographically, the South will remain the largest U.S. market, driven by Florida, Texas, North Carolina, Georgia, Tennessee, and other high-growth senior populations. The West will be the fastest-growing region, supported by California’s scale, Arizona’s retirement demographics, and strong adoption of connected and robotic rehabilitation technologies. The Northeast will remain a high-value evidence-driven market, while the Midwest will provide stable demand through large elderly populations, mature post-acute infrastructure, and persistent chronic-disease burden.

For manufacturers, investors, providers, distributors, and strategic buyers evaluating this market, the defining question is no longer whether geriatric rehabilitation demand will expand. The strategic issue is which technologies can convert demographic aging into measurable functional improvement while reducing the labor and economic burden of care. Products that help elderly patients walk safely, regain strength, reduce fall exposure, transition home sooner, maintain therapy adherence, and preserve independence will command the strongest clinical and commercial relevance through 2032.